Marie Foley Kijewski, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tomography, Emission-Computed, Single-Photon | 20 | 2020 | 1067 | 1.690 |
Why?
|
Amyloidosis | 11 | 2023 | 818 | 1.600 |
Why?
|
Cardiomyopathies | 10 | 2024 | 1945 | 0.870 |
Why?
|
Ethylene Glycols | 6 | 2024 | 190 | 0.820 |
Why?
|
Radiopharmaceuticals | 13 | 2024 | 2633 | 0.750 |
Why?
|
Aniline Compounds | 6 | 2024 | 1068 | 0.610 |
Why?
|
Positron-Emission Tomography | 14 | 2024 | 6457 | 0.550 |
Why?
|
Fluorine Radioisotopes | 4 | 2020 | 413 | 0.540 |
Why?
|
Image Enhancement | 5 | 2013 | 2877 | 0.520 |
Why?
|
Technetium Tc 99m Pyrophosphate | 4 | 2024 | 45 | 0.510 |
Why?
|
Amyloid Neuropathies, Familial | 3 | 2024 | 150 | 0.410 |
Why?
|
Myocardium | 8 | 2024 | 4688 | 0.360 |
Why?
|
Amyloid | 4 | 2023 | 843 | 0.330 |
Why?
|
Image Processing, Computer-Assisted | 9 | 2020 | 8945 | 0.310 |
Why?
|
Prealbumin | 4 | 2024 | 222 | 0.280 |
Why?
|
Corpus Striatum | 1 | 2013 | 1233 | 0.280 |
Why?
|
Technetium Tc 99m Exametazime | 4 | 2004 | 61 | 0.270 |
Why?
|
Whole Body Imaging | 1 | 2007 | 278 | 0.250 |
Why?
|
Heart | 5 | 2020 | 4392 | 0.250 |
Why?
|
Magnetic Resonance Imaging, Cine | 3 | 2021 | 1038 | 0.230 |
Why?
|
Putamen | 2 | 2022 | 291 | 0.230 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2019 | 2007 | 0.220 |
Why?
|
Phantoms, Imaging | 9 | 2022 | 2510 | 0.210 |
Why?
|
Tellurium | 2 | 2020 | 21 | 0.210 |
Why?
|
Ammonia | 1 | 2023 | 236 | 0.210 |
Why?
|
Brain | 11 | 2019 | 26912 | 0.200 |
Why?
|
Contrast Media | 3 | 2021 | 5301 | 0.200 |
Why?
|
Multiple Sclerosis | 4 | 2024 | 3202 | 0.200 |
Why?
|
Demyelinating Autoimmune Diseases, CNS | 1 | 2022 | 38 | 0.200 |
Why?
|
Equipment Failure Analysis | 3 | 2013 | 848 | 0.200 |
Why?
|
Gallium Radioisotopes | 1 | 2002 | 194 | 0.190 |
Why?
|
Pyruvates | 1 | 2021 | 84 | 0.190 |
Why?
|
Cadmium | 2 | 2020 | 215 | 0.190 |
Why?
|
Molecular Imaging | 3 | 2023 | 817 | 0.180 |
Why?
|
Sensitivity and Specificity | 13 | 2013 | 14656 | 0.180 |
Why?
|
Heart Failure | 2 | 2024 | 11835 | 0.170 |
Why?
|
Mesencephalon | 1 | 2022 | 332 | 0.170 |
Why?
|
D-Amino-Acid Oxidase | 1 | 2019 | 26 | 0.170 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2011 | 3335 | 0.170 |
Why?
|
Monte Carlo Method | 7 | 2012 | 1256 | 0.170 |
Why?
|
Predictive Value of Tests | 8 | 2024 | 15273 | 0.160 |
Why?
|
Thorax | 1 | 2002 | 553 | 0.160 |
Why?
|
Pyrrolidines | 1 | 2001 | 338 | 0.160 |
Why?
|
Substantia Nigra | 1 | 2020 | 350 | 0.160 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2024 | 615 | 0.150 |
Why?
|
Neuroglia | 1 | 2024 | 944 | 0.150 |
Why?
|
Zinc | 2 | 2020 | 690 | 0.150 |
Why?
|
Equipment Design | 4 | 2013 | 3520 | 0.150 |
Why?
|
Encephalitis | 1 | 2022 | 436 | 0.150 |
Why?
|
Reproducibility of Results | 13 | 2023 | 20048 | 0.150 |
Why?
|
Computer Simulation | 7 | 2012 | 6210 | 0.150 |
Why?
|
Algorithms | 9 | 2012 | 13967 | 0.150 |
Why?
|
Iodine Radioisotopes | 2 | 2001 | 1032 | 0.150 |
Why?
|
Phosphatidylcholines | 1 | 2018 | 406 | 0.140 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2019 | 254 | 0.140 |
Why?
|
Benzamides | 2 | 2007 | 1369 | 0.140 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2019 | 435 | 0.140 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2018 | 203 | 0.130 |
Why?
|
Abdomen | 1 | 2002 | 1124 | 0.130 |
Why?
|
Echocardiography, Doppler | 1 | 2020 | 900 | 0.130 |
Why?
|
Photons | 3 | 2012 | 581 | 0.130 |
Why?
|
Hydrogen Peroxide | 1 | 2019 | 732 | 0.130 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2024 | 1705 | 0.130 |
Why?
|
Protease Inhibitors | 1 | 2019 | 755 | 0.130 |
Why?
|
Fungal Proteins | 1 | 2019 | 911 | 0.120 |
Why?
|
Tyrosine | 1 | 2018 | 1440 | 0.120 |
Why?
|
Organotechnetium Compounds | 3 | 2020 | 129 | 0.110 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2019 | 556 | 0.110 |
Why?
|
Tetrazoles | 1 | 2019 | 901 | 0.110 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2019 | 819 | 0.110 |
Why?
|
Fatigue | 1 | 2020 | 1544 | 0.110 |
Why?
|
Ventricular Function, Left | 3 | 2024 | 3870 | 0.100 |
Why?
|
Humans | 54 | 2024 | 760261 | 0.100 |
Why?
|
Carotid Artery Diseases | 1 | 2019 | 881 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 10 | 2022 | 36247 | 0.100 |
Why?
|
Models, Statistical | 2 | 2012 | 5073 | 0.100 |
Why?
|
Peptide Fragments | 1 | 2024 | 5120 | 0.100 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2874 | 0.100 |
Why?
|
Microglia | 1 | 2020 | 1348 | 0.100 |
Why?
|
Myocytes, Cardiac | 1 | 2019 | 1656 | 0.090 |
Why?
|
Tuberous Sclerosis | 1 | 2018 | 1030 | 0.090 |
Why?
|
Alzheimer Disease | 5 | 2022 | 8551 | 0.090 |
Why?
|
Body Mass Index | 1 | 2007 | 12901 | 0.090 |
Why?
|
Normal Distribution | 2 | 2012 | 273 | 0.080 |
Why?
|
Cerebral Cortex | 2 | 2022 | 5755 | 0.080 |
Why?
|
Angiogenesis Inhibitors | 1 | 2018 | 2047 | 0.080 |
Why?
|
Middle Aged | 21 | 2024 | 220175 | 0.080 |
Why?
|
Male | 27 | 2024 | 359413 | 0.080 |
Why?
|
Acetanilides | 2 | 2020 | 169 | 0.080 |
Why?
|
Oxidative Stress | 1 | 2019 | 3107 | 0.080 |
Why?
|
Thyroid Neoplasms | 1 | 2021 | 2332 | 0.070 |
Why?
|
Aged | 19 | 2024 | 168995 | 0.070 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2013 | 572 | 0.070 |
Why?
|
Tomography, Emission-Computed | 3 | 1988 | 1121 | 0.070 |
Why?
|
Plaque, Atherosclerotic | 1 | 2019 | 1520 | 0.070 |
Why?
|
Female | 26 | 2024 | 391011 | 0.070 |
Why?
|
Tropanes | 1 | 2005 | 51 | 0.070 |
Why?
|
Neoplasms | 3 | 2011 | 22066 | 0.060 |
Why?
|
Rubidium Radioisotopes | 1 | 2005 | 77 | 0.060 |
Why?
|
Heart Diseases | 1 | 2018 | 2809 | 0.060 |
Why?
|
Pattern Recognition, Automated | 1 | 2011 | 988 | 0.060 |
Why?
|
Coronary Artery Disease | 3 | 2019 | 6661 | 0.060 |
Why?
|
Mitochondria | 1 | 2018 | 3598 | 0.060 |
Why?
|
Calibration | 2 | 1997 | 816 | 0.060 |
Why?
|
Stroke Volume | 1 | 2018 | 5513 | 0.060 |
Why?
|
Radionuclide Imaging | 3 | 2018 | 1975 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10757 | 0.060 |
Why?
|
Hypertension | 1 | 2024 | 8595 | 0.060 |
Why?
|
Multiple System Atrophy | 1 | 2005 | 129 | 0.060 |
Why?
|
Immunoglobulin Light Chains | 1 | 2024 | 278 | 0.050 |
Why?
|
Likelihood Functions | 2 | 2005 | 988 | 0.050 |
Why?
|
Computer-Aided Design | 1 | 2005 | 301 | 0.050 |
Why?
|
Glioblastoma | 1 | 2018 | 3482 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 5 | 2020 | 20484 | 0.050 |
Why?
|
Feasibility Studies | 4 | 2023 | 5201 | 0.050 |
Why?
|
Artifacts | 1 | 2011 | 1893 | 0.050 |
Why?
|
Amyloidogenic Proteins | 1 | 2023 | 151 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2019 | 3524 | 0.050 |
Why?
|
Models, Theoretical | 4 | 2005 | 3561 | 0.050 |
Why?
|
Heart Ventricles | 2 | 2024 | 3811 | 0.050 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2007 | 615 | 0.050 |
Why?
|
Pyrimidines | 2 | 2018 | 3011 | 0.050 |
Why?
|
Stochastic Processes | 1 | 2002 | 354 | 0.050 |
Why?
|
Pilot Projects | 3 | 2023 | 8553 | 0.050 |
Why?
|
Cysteine | 1 | 2005 | 897 | 0.050 |
Why?
|
Diphosphates | 1 | 2020 | 84 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 9274 | 0.040 |
Why?
|
Prospective Studies | 5 | 2024 | 54263 | 0.040 |
Why?
|
Models, Cardiovascular | 1 | 2005 | 974 | 0.040 |
Why?
|
Probability | 1 | 2005 | 2476 | 0.040 |
Why?
|
Scattering, Radiation | 2 | 2001 | 488 | 0.040 |
Why?
|
Quality Control | 1 | 2002 | 827 | 0.040 |
Why?
|
Parkinson Disease | 2 | 2005 | 2853 | 0.040 |
Why?
|
Fluoroacetates | 1 | 2018 | 14 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2005 | 2363 | 0.040 |
Why?
|
Technetium Tc 99m Medronate | 1 | 2018 | 131 | 0.040 |
Why?
|
Perfusion | 1 | 2023 | 1376 | 0.040 |
Why?
|
Finland | 1 | 2019 | 602 | 0.040 |
Why?
|
Coronary Circulation | 1 | 2024 | 1578 | 0.040 |
Why?
|
Brain Neoplasms | 2 | 2018 | 8984 | 0.040 |
Why?
|
Parotid Gland | 1 | 2019 | 175 | 0.040 |
Why?
|
Gamma Cameras | 1 | 1997 | 34 | 0.040 |
Why?
|
Motion | 1 | 2022 | 779 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2019 | 356 | 0.040 |
Why?
|
Mitochondria, Heart | 1 | 2019 | 229 | 0.040 |
Why?
|
Death Certificates | 1 | 2018 | 167 | 0.040 |
Why?
|
Radiotherapy | 1 | 1984 | 1505 | 0.040 |
Why?
|
Piperazines | 1 | 2007 | 2520 | 0.040 |
Why?
|
Injections, Intravenous | 1 | 2019 | 1388 | 0.040 |
Why?
|
Neprilysin | 1 | 2019 | 472 | 0.030 |
Why?
|
Choline | 1 | 2018 | 513 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2042 | 0.030 |
Why?
|
Receptors, LDL | 1 | 2019 | 491 | 0.030 |
Why?
|
Corpus Callosum | 1 | 2001 | 749 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2019 | 1849 | 0.030 |
Why?
|
Adult | 9 | 2024 | 219847 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2019 | 18134 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1897 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2024 | 58947 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2020 | 1181 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2019 | 2262 | 0.030 |
Why?
|
Biphenyl Compounds | 1 | 2019 | 988 | 0.030 |
Why?
|
Troponin T | 1 | 2019 | 774 | 0.030 |
Why?
|
Dependovirus | 1 | 2019 | 708 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2007 | 4044 | 0.030 |
Why?
|
Cerebellum | 1 | 2001 | 1495 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2024 | 0.030 |
Why?
|
Cerebrovascular Circulation | 2 | 2001 | 2731 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2394 | 0.030 |
Why?
|
Autoantibodies | 1 | 2022 | 2119 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3584 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2893 | 0.030 |
Why?
|
Nuclear Medicine | 1 | 1995 | 236 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2018 | 1840 | 0.020 |
Why?
|
Ventricular Remodeling | 1 | 2019 | 1259 | 0.020 |
Why?
|
Lyme Disease | 1 | 1997 | 630 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2024 | 3217 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2012 | 507 | 0.020 |
Why?
|
Dementia | 1 | 2004 | 2638 | 0.020 |
Why?
|
Time Factors | 2 | 2024 | 40133 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1902 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2019 | 3378 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8551 | 0.020 |
Why?
|
Animals | 5 | 2021 | 167940 | 0.020 |
Why?
|
Bone Marrow | 1 | 2019 | 2918 | 0.020 |
Why?
|
Brain Diseases | 1 | 1997 | 1540 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2019 | 2869 | 0.020 |
Why?
|
Bone and Bones | 1 | 2018 | 2560 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14482 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 5784 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7072 | 0.020 |
Why?
|
Cause of Death | 1 | 2018 | 3723 | 0.020 |
Why?
|
Prognosis | 2 | 2024 | 29636 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6775 | 0.020 |
Why?
|
Radiography | 2 | 2011 | 6965 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2018 | 1819 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15827 | 0.020 |
Why?
|
Mice | 3 | 2021 | 81216 | 0.020 |
Why?
|
Electroencephalography | 1 | 2022 | 6182 | 0.020 |
Why?
|
Models, Biological | 1 | 2002 | 9468 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9531 | 0.020 |
Why?
|
Echocardiography | 1 | 2018 | 4980 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2021 | 10434 | 0.020 |
Why?
|
Software | 1 | 2019 | 4420 | 0.020 |
Why?
|
Analog-Digital Conversion | 1 | 1984 | 23 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2021 | 16905 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11064 | 0.010 |
Why?
|
United States | 3 | 2020 | 72363 | 0.010 |
Why?
|
Brain Ischemia | 1 | 1997 | 3127 | 0.010 |
Why?
|
Young Adult | 2 | 2022 | 58673 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2019 | 14396 | 0.010 |
Why?
|
Apoptosis | 1 | 2019 | 9497 | 0.010 |
Why?
|
Cohort Studies | 2 | 2018 | 41317 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 18968 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 24086 | 0.010 |
Why?
|
Technology, Radiologic | 1 | 1983 | 160 | 0.010 |
Why?
|
Rats | 1 | 2018 | 23695 | 0.010 |
Why?
|
Mathematics | 2 | 1995 | 708 | 0.010 |
Why?
|
Lung | 1 | 2019 | 9989 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39254 | 0.010 |
Why?
|
Bayes Theorem | 2 | 2001 | 2325 | 0.010 |
Why?
|
Biophysical Phenomena | 1 | 2001 | 320 | 0.010 |
Why?
|
Biophysics | 1 | 2001 | 380 | 0.010 |
Why?
|
Patient Care Planning | 1 | 1984 | 909 | 0.010 |
Why?
|
Risk Factors | 1 | 2024 | 74269 | 0.010 |
Why?
|
Ceftriaxone | 1 | 1997 | 175 | 0.010 |
Why?
|
Cephalosporins | 1 | 1997 | 204 | 0.010 |
Why?
|
Memory Disorders | 1 | 2003 | 1197 | 0.010 |
Why?
|
Tungsten | 1 | 1995 | 19 | 0.010 |
Why?
|
Aging | 1 | 1993 | 8641 | 0.010 |
Why?
|
Adolescent | 1 | 2022 | 87747 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 80301 | 0.010 |
Why?
|
Oximes | 1 | 1993 | 306 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 3804 | 0.010 |
Why?
|
Reference Values | 1 | 1997 | 4920 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2005 | 12968 | 0.010 |
Why?
|
Observer Variation | 1 | 1995 | 2596 | 0.010 |
Why?
|
Sodium Pertechnetate Tc 99m | 1 | 1986 | 55 | 0.000 |
Why?
|
Amphetamines | 1 | 1986 | 143 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2007 | 13629 | 0.000 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 1988 | 1490 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2007 | 64947 | 0.000 |
Why?
|
ROC Curve | 1 | 1988 | 3568 | 0.000 |
Why?
|
Cerebrovascular Disorders | 1 | 1986 | 1500 | 0.000 |
Why?
|
Mental Disorders | 1 | 1997 | 6797 | 0.000 |
Why?
|